Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises $1.5M in Private Placement

NEW YORK (GenomeWeb News) – GeneNews this week said that it had closed the first tranche of a private placement offering of its common shares, raising C$1.7 million (US$1.5 million).

The Toronto-based firm issued around 6.8 million common shares at a price of C$.25 per share. It plans to use the proceeds to support continued marketing of its ColonSentry test in Canada, and for pre-launch activities for the test in the US, Europe, and Asia.

Earlier this year, GeneNews raised around C$1.8 million through two private placement tranches of convertible secured debentures.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.